期刊文献+

以国际通用标准评价五种胱抑素C试剂的方法学性能 被引量:4

Methodology performance evaluation on five different detection systems of Cystatin C by international general standard
暂未订购
导出
摘要 目的对五个不同厂家血清胱抑素C(CysC)检测系统的分析性能进行评价和验证。方法采用美国雅培C16000全自动生化分析仪与五个不同厂家胱抑素C试剂组成的检测系统测定血清胱抑素C,评价的方法学性能指标为精密度、线性、抗干扰性及偏倚。结果 CysC浓度在0.9~7.1mg/L时,各厂家试剂总不精密度(CV)<6%。在0.6~5.6mg/L浓度范围,各厂家均有良好的线性范围。血清中一定浓度的胆红素、血红蛋白和乳糜对五个厂家CysC的测定结果产生不同程度的影响,但与厂家声明相符。除利德曼外各厂家的偏倚均小于15%。结论五个厂家CysC试剂的主要分析性能:精密度、线性、抗干扰性、偏倚的验证结果与厂家声明基本一致,但利德曼试剂测定结果与Randox质控品存在偏差。 Objective To evaluate and verify the analytic performance of five different Cystatin C(Cys C) detection kits.Methods Cys C was detected by Abbott C16000 automatic biochemical analyzer and five kinds of Cys C reagent.The precision,linearity,interference and bias of five detection systems were analyzed.Results The total coefficient of variations(CV) of the five reagents were all less than 6% for detecting samples with the concentration of Cys C for 0.9-7.1 mg/L.Within the range of 0.6-5.6 mg/L,the five reagent kits were with good linearity.The detection outcome was interfered to various degree by bilirubin,haematoglobin and chyle,but the interference was consistent with the proclaim of manufacturer.Bias of four kinds of reagents were less than 15%,except for LEADMAN reagent.Conclusion The primary analytic performance,including precision,linearity,interference and bias,of the five kits might be consistent with the analytical performance defined by manufacturer,but there could be with bias between the results of LEADMAN kit and Randox control materials.
出处 《国际检验医学杂志》 CAS 2012年第13期1584-1586,1589,共4页 International Journal of Laboratory Medicine
关键词 胱抑素C 方法学性能 偏倚 Cystatin; methodologic performance; bias
  • 相关文献

参考文献12

  • 1徐国宾,蒋琳.临床生物化学常规定量方法的分析性能评价[J].中华检验医学杂志,2007,30(6):718-720. 被引量:58
  • 2Ehrmeyer SS, Laessing RH. Has compliance with CLIA require- ments really improved quality in US clinical laboratories[J]. Clin Acta, 2004,346 (1) : 37-43.
  • 3Reed CH. Diagnostic applications of cystatin C[J]. Br J Biomed Sci,2000,57(4):323-329.
  • 4Dhamidharka VR,Kwon C,Stevens G. Serum Cys C is superior to serum creatinine as a marker of kidney function: a meta-analysis[J]. Am J Kidney Dis,2002,40(2):221-226.
  • 5Clinical and Laboratory Standards Institute. Evaluation of preci- sion performance of quantative measurement methods. approved guideline-second edition[S]. EPS-A2, CLSI, 2004,24 (25) : 1-38.
  • 6Clinical and Laboratory Standards Institute. Evaluation of the lin- earity of quantative measurement procedures: A Statistical Ap- proach; Approved Guideline[S]. EP6-A2, CLSI, 2003,23 (16) : 1- 46.
  • 7Clinical and Laboratory Standards Institute. Interference testing in clinical chemistry; approved guideline-second edition[S]. EP7-A2, CLSI,2005,25(27) : 1-51.
  • 8Department of Health and Human services, Centers for Medicare Medicaid services. Clinical laboratory improvement amendments of 1988 : final rule[J]. Fed Register, 2003,24(16):3640-3740.
  • 9李海霞,王学晶,徐国宾,李淑葵,夏铁安.两种不同检测系统测定半胱氨酸蛋白酶抑制剂C的方法学评价[J].中华检验医学杂志,2007,30(11):1284-1287. 被引量:16
  • 10陶华林,汪碧琼.医疗机构临床实验室间检验结果互认的探讨[J].现代检验医学杂志,2009,24(1):23-24. 被引量:9

二级参考文献10

共引文献75

同被引文献33

  • 1李海霞,吴红花,徐国宾,郭晓蕙,夏铁安.血清半胱氨酸蛋白酶抑制剂C与肌酐在评价糖尿病患者肾小球滤过功能中的比较研究[J].中华检验医学杂志,2005,28(6):602-605. 被引量:107
  • 2徐国宾,蒋琳.临床生物化学常规定量方法的分析性能评价[J].中华检验医学杂志,2007,30(6):718-720. 被引量:58
  • 3冯仁峰.临床检验质量管理技术基础[M].上海:上海科学技术文献出版社,2007:37.
  • 4张秀明,温冬梅,袁勇.临床生物化学检验质量管理与标准操作程序[M].北京:人民军医出版社,2007:103.
  • 5杨振华主编.临床实验室质量管理[M].北京:人民卫生出版社,2004,109—110.
  • 6National Committee for Clinical Laboratory Standards. Preliminary Evaluation of Quantitative Clinical Laboratory Methods; Ap- proved Guideline[ S]. EP10 - A2. NCCLS,2002.
  • 7National Committee for Clinical Laboratory Standards.Preliminary Evaluation of Quantitative Clinical Laboratory Methods;Approved Guideline[S].EP10-A2.NCCLS,2002.
  • 8Dharnidharka VR,Kwon C,Stevens G. Serum cystatinC is superior to serum creatinine as a marker of kid-ney function : a meta-analysis[ J] . Am J Kidney Dis,2002,40(2) :221-226.
  • 9Clinical and Laboratory Standards Institute. Evalua-tion of precision performance of quantitative measure-ment methods ; approved guideline-second edition[S].EP5-A2,CLSI,2004.
  • 10Centers for Medicare and Medicaid Services. Clinicallaboratory improvement amendments of 1988 [ S ].CLIA88, CMS,1988.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部